A 6-month-old infant with β-thalassemia intermedia presents with moderate hemolytic anemia and jaundice. The parents request investigation to assess the severity of hemolysis and predict the clinical course. Which investigation is most appropriate for this purpose?

Explanation

## Assessment of Hemolysis Severity in Thalassemia Intermedia ### Reticulocyte Count as a Marker of Hemolysis **Key Point:** The reticulocyte count is the single most reliable indicator of the rate of hemolysis and bone marrow erythropoietic response. In thalassemia intermedia, a markedly elevated reticulocyte count (often 5–10% or higher) reflects severe ongoing hemolysis and compensatory erythropoiesis. ### Why Reticulocyte Count Predicts Clinical Course 1. **Hemolysis severity**: Higher reticulocyte counts indicate greater RBC destruction 2. **Marrow compensation**: Reflects the adequacy of bone marrow response 3. **Transfusion need prediction**: Helps stratify patients into transfusion-dependent vs. transfusion-independent categories 4. **Disease progression**: Serial reticulocyte counts track disease trajectory ### Peripheral Blood Smear Findings **High-Yield:** In thalassemia intermedia, smear shows: - Severe microcytosis and hypochromia - Target cells and schistocytes (fragmented RBCs from hemolysis) - Nucleated RBCs (indicating extramedullary erythropoiesis) - Polychromasia (immature RBCs reflecting high reticulocyte count) These morphologic findings, combined with reticulocyte count, provide a complete picture of hemolysis and marrow response. ### Comparison with Other Investigations | Investigation | Role in Thalassemia | Limitation | |---|---|---| | **Reticulocyte count + smear** | Assesses hemolysis severity and marrow response | Direct measure of current hemolytic state | | Serum ferritin | Assesses iron overload (chronic complication) | Does not reflect acute hemolysis severity | | Bone marrow biopsy | Evaluates marrow cellularity and dysplasia | Invasive; not needed for routine severity assessment | | Spleen ultrasound | Detects extramedullary hematopoiesis | Anatomic finding; does not quantify hemolysis | **Clinical Pearl:** In thalassemia intermedia, the reticulocyte count often remains elevated (3–10%) even at baseline, distinguishing it from thalassemia major (where transfusions suppress reticulocytosis) and thalassemia trait (where reticulocyte count is normal or mildly elevated).